Registry of Lobbyists
sanofi-aventis Canada Inc.
Subject matters | Details | Categories |
---|---|---|
Intellectual Property
|
Comprehensive Economic and Trade Agreement Negotiations as it relates to the protection of intellectual property rights.
|
Policies or Program, Regulation, Legislative Proposal, Bill or Resolution
|
Health
|
Federal public drug plans, specifically the Non-Insured Health Benefits Program (Health Canada), with respect to decisions and policies that impact reimbursement of therapeutic products for plan beneficiaries
|
Policies or Program
|
Health
|
Food and Drugs Act Regulations, specifically with respect to approval, regulation and life-cycle management of therapeutic products
|
Regulation, Legislative Proposal, Bill or Resolution
|
Economic Development
|
Innovation, Science and Economic Development Canada , particularly with respect to the life sciences priority under the S&T Strategy
|
Policies or Program
|
Intellectual Property
|
Patent Act as it relates to the regulation of intellectual property for therapeutic products
|
Legislative Proposal, Bill or Resolution
|
Intellectual Property
|
Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations.
|
Legislative Proposal, Bill or Resolution, Regulation
|
Health
|
Patented Medicines Prices Review Board with respect to amendments to the guidelines for the regulation of pricing of patented drug products patentees
|
Regulation
|
Health
|
Patented Medicines Prices Review Board with respect to decisions on the reporting obligations of patented drug products patentees
|
Regulation, Policies or Program
|
Health
|
Policy or program: National pharmacare with respect to the coordinaton of drug plan policies and programs
|
Policies or Program
|
Science and Technology
|
Research and Development Legislative Proposal, Policy or Program, with respect to the strategy on innovation.
|
Policies or Program
|